Andreas Schwarting
Overview
Explore the profile of Andreas Schwarting including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
2260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dreher M, Petros S, Engelhardt S, Geselle L, Baab J, Wicke T, et al.
BMJ Open Sport Exerc Med
. 2025 Feb;
11(1):e002403.
PMID: 39974335
The symptoms of active systemic lupus erythematosus (SLE) potentially lead to inactivity, muscle loss and social isolation. In addition to medical treatment, the current EULAR recommendations describe the relevance of...
2.
Triantafyllias K, Alhaddad M, Schwarting A, Balaklytska V, Baraliakos X
Arthritis Res Ther
. 2025 Jan;
27(1):17.
PMID: 39885525
Background: Optical spectral transmission (OST) is a modern diagnostic method capable of quantifying inflammation in the finger and wrist joints of arthritis patients by assessing the blood-specific absorption of light...
3.
Triantafyllias K, Alhaddad M, Baraliakos X, Muthuraman M, Schwarting A
Rheumatology (Oxford)
. 2025 Jan;
PMID: 39752326
Objective: To examine the longitudinal associations of optical spectral transmission (OST) with clinical inflammatory arthritis activity markers in order to investigate its potential in monitoring disease activity. Methods: OST measurements...
4.
Triantafyllias K, Gauch S, Bertsias G, Boumpas D, Hasseli R, Cavagna L, et al.
Rheumatology (Oxford)
. 2024 Dec;
PMID: 39672800
Objectives: To evaluate the combination of novel colour Doppler ultrasound (CDUS), greyscale ultrasound (GSUS), and oscillometric indices of macroangiopathy in patients with idiopathic inflammatory myopathies (IIM). Second, to explore the...
5.
Triantafyllias K, Altamimi K, Schederecker F, Schwarting A
Arthritis Res Ther
. 2024 Sep;
26(1):165.
PMID: 39304933
Objectives: The aims of this study were to suggest patient-adjusted optical spectral transmission (OST) cut-off values for the first time and to develop clinical models that predict the probability of...
6.
Triantafyllias K, Balaklytska V, Sauer C, Dreher M, Schwarting A
Z Rheumatol
. 2024 Sep;
84(1):10-18.
PMID: 39292267
Introduction: Fibromyalgia syndrome (FMS) is a complex condition that is often refractory to therapy and is associated with impaired quality of life. In some studies, multimodal rheumatological treatment has been...
7.
Triantafyllias K, Liverakos S, Muthuraman M, Cavagna L, Parodis I, Schwarting A
Rheumatol Ther
. 2024 May;
11(4):897-911.
PMID: 38819779
Introduction: Psoriatic arthritis (PsA) is associated with increased cardiovascular (CV) risk and mortality. Aortic stiffness measured by carotid-femoral pulse wave velocity (cfPWV) has been shown to predict CV risk in...
8.
Mockel T, Boegel S, Schwarting A
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791453
Chronic kidney disease (CKD) is an emerging cause for morbidity and mortality worldwide. Acute kidney injury (AKI) can transition to CKD and finally to end-stage renal disease (ESRD). Targeted treatment...
9.
Askanase A, Furie R, DallEra M, Bomback A, Schwarting A, Zhao M, et al.
Lupus Sci Med
. 2024 May;
11(1).
PMID: 38777595
Our 2022 published working definition of disease modification in systemic lupus erythematosus (SLE) was 'minimising disease activity with the fewest treatment-associated toxicities and slowing or preventing organ damage progression'. The...
10.
Triantafyllias K, Clasen M, De Blasi M, Berres M, Nikolodimos E, Schwarting A
Clin Exp Rheumatol
. 2024 May;
42(9):1802-1811.
PMID: 38757297
Objectives: To examine the value of a novel high-resolution thermographic marker in the detection of joint inflammation compared to joint ultrasound (US) and to suggest thermographic cut-off values of joint...